Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 4, 2011, Pages 586-593

  Pahan, Kalipada ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

Adaptive immunity; EAE; Glial activation; Innate immunity; Neuroinflammation; Signal transduction; Sodium benzoate

Indexed keywords

BENZOIC ACID; PROTEIN P21;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CELL ACTIVATION; CELL CONTACT; CELL MIGRATION; CINNAMON; DISEASE COURSE; GLIA CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROGLIA; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FOOD PRESERVATIVES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MICE; MULTIPLE SCLEROSIS; NEUROGLIA; SIGNAL TRANSDUCTION; SODIUM BENZOATE; T-LYMPHOCYTES, HELPER-INDUCER;

ANIMALIA; CINNAMOMUM VERUM;

EID: 80052454489     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.561861     Document Type: Review

References (51)

1. Parkinson, J.F., Mitrovic, B., Merrill, J.E. The role of nitric oxide in multiple sclerosis. J Mol Med 1997, 75, 174-186. (Pubitemid 27132680)
2. Brück, W., Stadelmann, C. Inflammation and degeneration in multiple sclerosis. Neurol Sci 2003, 24 Suppl 5, S265-S267. (Pubitemid 37493197)
3. Martin, R., McFarland, H.F., McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10, 153-187.
4. Swanborg, R.H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 1995, 77, 4-13.
5. Tuohy, V.K., Sobel, R.A., Lees, M.B. Myelin proteolipid proteininduced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J Immunol 1988, 140, 1868-1873.
6. Pahan, K. Neuroimmune pharmacological control of EAE. J Neuroimmune Pharmacol 2010, 5, 165-167.
7. Libbey, J.E., Tsunoda, I., Fujinami, R.S. Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010, 5, 168-175.
8. + T cells in EAE. J Neuroimmune Pharmacol 2010, 5, 176-188.
9. Becher, B., Bechmann, I., Greter, M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 2006, 84, 532-543. (Pubitemid 43992845)
10. Toth, B. Lack of tumorigenicity of sodium benzoate in mice. Fundam Appl Toxicol 1984, 4, 494-496. (Pubitemid 14010959)
11. Bridges, J.W., French, M.R., Smith, R.L., Williams, R.T. The fate of benzoic acid in various species. Biochem J 1970, 118, 47-51.
12. Kubota, K., Ishizaki, T. Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans. Eur J Clin Pharmacol 1991, 41, 363-368.
13. Abd El-Mawla, A.M., Schmidt, W., Beerhues, L. Cinnamic acid is a precursor of benzoic acids in cell cultures of Hypericum androsaemum L. but not in cell cultures of Centaurium erythraea RAFN. Planta 2001, 212, 288-293. (Pubitemid 32139886)
14. Jana, A., Pahan, K. Sphingolipids in multiple sclerosis. Neuromolecular Med 2010, 12, 351-361.
15. El-behi, M., Rostami, A., Ciric, B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010, 5, 189-197.
16. Chen, Z., Freedman, M.S. Gammadelta T cells and multiple sclerosis: Friends, foes, or both? Autoimmun Rev 2010 Dec 30.
17. Dasgupta, S., Roy, A., Jana, M., Hartley, D.M., Pahan, K. Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha. Mol Pharmacol 2007, 72, 934-946. (Pubitemid 47481416)
18. Brahmachari, S., Pahan, K. Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol 2007, 179, 275-283. (Pubitemid 46986543)
19. Brahmachari, S., Jana, A., Pahan, K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 2009, 183, 5917-5927.
20. Coffer, P.J., Burgering, B.M. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004, 4, 889-89 (Pubitemid 39490764)
21. + Tregs: limiting collateral damage. J Clin Invest 2004, 114, 1372-1378. (Pubitemid 40385564)
22. +CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 2003, 170, 394-399. (Pubitemid 36026164)
23. Brahmachari, S., Pahan, K. Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide. J Immunol 2010, 184, 1799-1809.
24. Brahmachari, S., Pahan, K. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 2009, 183, 2045-2058.
25. Steinman, L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009, 9, 440-447.
26. Brahmachari, S., Pahan, K. Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis. J Immunol 2010, 184, 6103-6113.
27. Dasgupta, S., Jana, M., Liu, X., Pahan, K. Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells. J Biol Chem 2003, 278, 22424-22431. (Pubitemid 36830294)
28. Roy, A., Liu, X., Pahan, K. Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin. J Biol Chem 2007, 282, 32222-32232. (Pubitemid 350106469)
29. Benveniste, E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997, 75, 165-173. (Pubitemid 27132679)
30. Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996, 85, 299-302. (Pubitemid 26160700)
31. Saha, R.N., Pahan, K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 2006, 8, 929-947. (Pubitemid 44036510)
32. Pahan, K., Sheikh, F.G., Namboodiri, A.M., Singh, I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997, 100, 2671-2679. (Pubitemid 28007534)
33. Pahan, K., Liu, X., McKinney, M.J., Wood, C., Sheikh, F.G., Raymond, J.R. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes. J Neurochem 2000, 74, 2288-2295. (Pubitemid 30314203)
34. Ghosh, S., Hayden, M.S. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8, 837-848.
35. Ling, E.A., Wong, W.C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993, 7, 9-18.
36. González-Scarano, F., Baltuch, G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999, 22, 219-240. (Pubitemid 29144887)
37. Roy, A., Fung, Y.K., Liu, X., Pahan, K. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 2006, 281, 14971-14980. (Pubitemid 43855201)
38. von Andrian, U.H., Mackay, C.R. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000, 343, 1020-1034.
39. Vajkoczy, P., Laschinger, M., Engelhardt, B. Alpha4-integrin- VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest 2001, 108, 557-565. (Pubitemid 32777735)
40. Steffen, B.J., Butcher, E.C., Engelhardt, B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994, 145, 189-201. (Pubitemid 24217497)
41. Eng, L.F., Ghirnikar, R.S. GFAP and astrogliosis. Brain Pathol 1994,4, 229-237. (Pubitemid 24261929)
42. Saha, R.N., Pahan, K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int 2006, 49, 154-163. (Pubitemid 43867073)
43. Saha, R.N., Jana, M., Pahan, K. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol 2007, 179, 7101-7109.
44. Nagele, R.G., Wegiel, J., Venkataraman, V., Imaki, H., Wang, K.C., Wegiel, J. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004, 25, 663-674. (Pubitemid 38686490)
45. Brahmachari, S., Fung, Y.K., Pahan, K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006, 26, 4930-4939. (Pubitemid 44315335)
46. Jana, A., Hogan, E.L., Pahan, K. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci 2009, 278, 5-15.
47. Miller, A. Current and investigational therapies used to alter the course of disease in multiple sclerosis. South Med J 1997, 90, 367-375. (Pubitemid 27176396)
48. Barkhatova, V.P., Zavalishin, I.A., Askarova, L.S.h., Shavratskii, V.K.h., Demina, E.G. Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol 1998, 28, 341-344. (Pubitemid 128695890)
49. Nair, B. Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate. Int J Toxicol 2001, 20 Suppl 3, 23-50.
50. Leonard, J.V., Morris, A.A. Urea cycle disorders. Semin Neonatol 2002, 7, 27-35. (Pubitemid 34742217)
51. Scaglia, F., Carter, S., O'Brien, W.E., Lee, B. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol Genet Metab 2004, 81 Suppl 1, S79-S85. (Pubitemid 38402240)